2030年体内临床前脑成像设备市场规模和份额

体内临床前脑成像设备市场分析和规模

全球体内临床前脑成像设备市场在促进我们对大脑、神经系统疾病和药物开发的理解方面发挥着至关重要的作用。体内临床前脑成像设备为研究人员提供了研究活体动物大脑结构和功能的工具。这对于促进我们对大脑生理、认知和行为的理解至关重要。制药和生物技术公司依靠临床前脑成像来评估针对神经系统疾病（如阿尔茨海默病、帕金森病和精神疾病）的新药和疗法的有效性和安全性。

Data Bridge Market Research 分析称，全球体内临床前脑成像设备市场预计到 2030 年将达到 1,124,983.68 万美元的价值，预测期内的复合年增长率为 5.9%。

本市场报告还深入介绍了定价分析和技术进步。

报告指标	细节
预测期	2023 至 2030 年
基准年	2022
历史岁月	2021（可定制为 2015 - 2020）
定量单位	收入（千美元）
涵盖的领域	成像方式类型（MRI、PET/SPECT、CT、光学微型内窥镜、2 光子共焦、US、NIR 荧光、OCT、生物发光等）、应用（药物研发、疾病表征和毒理学）、治疗领域（阿尔茨海默病、帕金森病、肿瘤学和其他治疗领域）、生物变量（BOLD、氧合、血流、微血管、神经元活动和软组织）、使用时间格式（一小时内、数小时和纵向）、最终用户（制药公司内部、CRO、学术界等）
覆盖国家	美国、加拿大、墨西哥、德国、法国、英国、意大利、西班牙、俄罗斯、土耳其、比利时、荷兰、瑞士、欧洲其他地区、日本、中国、韩国、印度、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区
涵盖的市场参与者	PerkinElmer Inc.、FUJIFILM Corporation、Mediso Ltd.、Spectral Instruments Imaging、MR Solutions、Charles River Laboratories、Aspect Imaging Ltd.、Bruker、Miltenyi Biotec、MILabs BV 和 Cubresa Inc.

市场定义

在体临床前脑成像设备是生物医学研究中使用的工具，用于可视化和研究活体动物（通常是啮齿动物，如小鼠和大鼠）的脑结构、功能和过程。这些设备在促进对神经生物学、神经系统疾病的理解和潜在疗法的开发方面发挥着关键作用。它们涵盖了多种技术，旨在非侵入性地捕获高分辨率的脑图像，为研究人员提供有关神经活动和病理的宝贵见解。

全球体内临床前脑成像设备市场动态

本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：

驱动程序

神经系统疾病患病率上升

神经系统疾病（例如阿尔茨海默病、帕金森病、多发性硬化症和各种神经发育障碍）的患病率不断上升，这促使人们加大研究力度。研究人员致力于更好地了解这些疾病的潜在机制、早期检测和潜在治疗方法。

随着全球神经系统疾病的患病率不断上升，对有效诊断、治疗和干预措施的需求也日益增长。体内临床前脑成像设备是不可或缺的工具，有助于更深入地了解这些疾病并开发创新解决方案，使其成为医疗保健和研究领域的重要组成部分。

因此，预计预测期内神经系统疾病患病率的上升将推动市场的增长。

脑成像中使用的成像技术的进展

成像技术的进步显著提高了脑成像的空间分辨率和灵敏度。更高分辨率的图像为研究人员提供了有关大脑结构和功能的更详细信息。这种清晰度的提高对于研究精细的解剖细节和检测与神经系统疾病或实验治疗相关的细微变化至关重要。现代临床前脑成像设备通常提供多模式功能，使研究人员能够在一项研究中结合多种成像技术。例如，将磁共振成像 (MRI) 与正电子发射断层扫描 (PET) 或单光子发射计算机断层扫描 (SPECT) 相结合可以提供有关大脑结构、代谢和功能的互补信息。这种多功能性增强了临床前研究的深度和范围。

功能性脑成像（例如功能性磁共振成像 (fMRI) 和 PET）的进步使研究人员能够实时研究大脑活动。这对于理解神经网络、认知过程以及神经系统疾病如何影响大脑功能至关重要。功能成像在评估潜在疗法的有效性方面也发挥着关键作用。动态成像技术（包括动态对比增强磁共振成像和动态 PET）使研究人员能够捕捉大脑生理和功能随时间的变化。这些技术对于跟踪疾病进展和评估干预措施对血流、新陈代谢和神经递质活动等动态过程的影响非常有用。

因此，预计预测期内手术技术的进步将推动市场的增长。

机会

主要市场参与者不断提升的战略举措

由于主要市场参与者采取了积极的战略举措，体内临床前脑成像设备市场正在经历大幅增长。这些举措为市场扩张和发展创造了机会。

市场领导者、学术机构、研究组织和制药公司之间的战略伙伴关系和合作促进了知识共享和资源共享。此类合作加速了尖端成像技术的开发，并增强了使用活体脑成像对新候选药物的验证。

此外，通过建立全球子公司和分销网络扩大地理覆盖范围，使这些设备更容易被世界各地的研究人员和机构使用。这种扩张进入了新兴市场，从而推动了神经科学研究和药物开发的兴起。

此外，针对特定研究需求定制的解决方案和服务以及多样化的产品组合可以满足更广泛的客户需求，通过满足多样化的研究需求来推动市场增长。

因此，主要市场参与者上述积极的战略举措可能为市场增长创造机会，使研究人员和制药公司更容易获得、更精确地使用先进的成像技术。

克制/挑战

由于技术进步导致专业技能人才匮乏

体内临床前脑成像设备市场是医学成像和神经科学研究领域中的一个重要领域。这些设备在促进我们对脑功能和疾病的理解方面发挥着关键作用。然而，由于缺乏能够操作和解释这些尖端设备所生成数据的熟练专业人员，市场的增长面临巨大挑战。

体内临床前脑成像设备是一种先进的工具，它利用各种成像方式，例如磁共振成像 (MRI)、正电子发射断层扫描 (PET) 和单光子发射计算机断层扫描 (SPECT)，来捕捉活体动物（通常是啮齿动物）的大脑详细图像。这些图像可帮助研究人员研究大脑结构、功能和新陈代谢，促进阿尔茨海默病、帕金森病和精神分裂症等神经系统疾病的治疗方法的开发。

缺乏熟练专业人员是该市场面临的重大挑战的主要原因之一是所涉及技术的复杂性。操作和解释体内临床前脑成像设备的数据需要深入了解神经解剖学、成像物理学和数据分析技术。专业人员需要熟练使用专业软件，并具备强大的分析能力，才能从图像中得出有意义的推论。

此外，神经科学和神经成像领域正在迅速发展，新技术不断涌现。这需要专业人员不断学习和适应，才能保持在该领域的领先地位。因此，对能够跟上最新进展并有效应用这些进展的训练有素的人才的需求很高。

因此，熟练专业人员的稀缺不仅限制了这些设备的采用，而且还可能妨碍研发工作的质量。

近期发展

2022 年 11 月，布鲁克宣布收购 Inscopix, Inc.，这是一家神经科学先驱和微型显微镜（称为微型显微镜）的市场领导者，用于自由移动的动物大脑成像。这有助于该组织创造更多收入。
2022 年 5 月，富士胶片公司宣布推出 Vevo F2，这是世界上第一款用于临床前用途的超高频至低频 (71MHz-1MHz) 超声和光声成像系统。Vevo F2 采用高清图像处理技术，并引入了一条全新的信号通路——从传感器到显示屏。这提高了图像清晰度，与多线处理相结合，与上一代平台相比，帧速率显著提高。
2022 年 4 月，PerkinElmer, Inc. 宣布推出 Vega 成像系统，扩大其体内成像产品组合。此举增加了公司的产品组合和总收入。
2021 年 12 月，专注于技术型的全球投资公司 Battery Ventures 收购了 LI-COR Biosciences，这是一家行业领先的公司，为环境研究、农业、药物研发、蛋白质研究和治疗学开发制造高度工程化的仪器系统。
2021 年 10 月，MR Solutions 宣布推出一款新型 AI，彻底改变了用于临床前研究的磁共振成像 (MRI)。这有助于该组织创造更多收入。

全球体内临床前脑成像设备市场范围

根据成像方式类型、应用、治疗领域、生物变量、使用时间格式和最终用户，全球体内临床前脑成像设备市场可分为六个显著的细分市场。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

影像设备类型

磁共振成像
正电子发射断层扫描/单光子发射计算机断层扫描
CT
光学微型显微镜
双光子共焦
我们
近红外荧光
10月
生物发光
其他的

根据成像方式类型，市场细分为 MRI、PET/SPECT、CT、光学微型内窥镜、双光子共聚焦、US、NIR 荧光、OCT、生物发光等。

应用

药物研发
疾病表征
毒理学

根据应用，市场分为药物发现、疾病表征和毒理学。

治疗领域

阿尔茨海默病
帕金森病
肿瘤学
其他治疗领域

根据治疗领域，市场细分为阿尔茨海默病、帕金森病、肿瘤学和其他治疗领域。

生物变量

大胆的
氧合
血流（量
微血管
神经元活动
软组织

根据生物变量，市场细分为BOLD、氧合、血流、微血管、神经活动和软组织。

使用时间格式

不到一小时
许多小时
纵向

根据使用的时间格式，市场分为一小时以内、多小时和纵向。

最终用户

制药厂内部
首席风险官
学术界
其他的

根据最终用户，市场细分为制药内部、CRO、学术界和其他。

全球体内临床前脑成像设备市场区域分析/见解

对全球体内临床前脑成像设备市场进行了分析，并按国家、成像方式类型、应用、治疗领域、生物变量、使用时间格式和最终用户提供了市场规模洞察和趋势。

本市场报告涵盖的国家包括美国、加拿大、墨西哥、德国、法国、英国、意大利、西班牙、俄罗斯、土耳其、比利时、荷兰、瑞士、欧洲其他地区、日本、中国、韩国、印度、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列以及中东和非洲其他地区。

由于对脑成像设备的需求不断增长，北美占据了市场主导地位，占有最大的市场份额。由于技术进步不断提高，美国是北美地区的主导国家。由于体内成像系统的采用不断增加，德国是欧洲地区的主导国家。由于神经系统疾病患病率不断上升，日本是亚太地区的主导国家。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势、波特五力分析和案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。

竞争格局和全球体内临床前脑成像设备市场份额分析

全球体内临床前脑成像设备市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

该市场的一些主要市场参与者包括 PerkinElmer Inc.、FUJIFILM Corporation、Mediso Ltd.、Spectral Instruments Imaging、MR Solutions、Charles River Laboratories、Aspect Imaging Ltd.、Bruker、Miltenyi Biotec、MILabs BV 和 Cubresa Inc. 等。

SKU-70242

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 2 GLOBAL MRI IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 3 GLOBAL PET/SPECT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 4 GLOBAL CT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 5 GLOBAL OPTICAL MINISCOPES IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 6 GLOBAL 2 PHOTON CONFOCAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 7 GLOBAL US IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 8 GLOBAL NIR FLUORESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 9 GLOBAL OCT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 10 GLOBAL BIOLUMINESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 11 GLOBAL OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 12 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 13 GLOBAL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 14 GLOBAL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 15 GLOBAL DISEASE CHARACTERIZATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 16 GLOBAL TOXICOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 17 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 18 GLOBAL ALZHEIMER'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 19 GLOBAL PARKINSON'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 20 GLOBAL ONCOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 21 GLOBAL OTHER THERAPEUTIC AREAS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 22 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)

TABLE 23 GLOBAL BOLD IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 24 GLOBAL OXYGENATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 25 GLOBAL BLOOD FLOW IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 26 GLOBAL MICROVESSELS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 27 GLOBAL NEURONAL ACTIVITY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 28 GLOBAL SOFT TISSUE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 29 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 30 GLOBAL UNDER AN HOUR IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 31 GLOBAL MANY HOURS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 32 GLOBAL LONGITUDINAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 33 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 34 GLOBAL PHARMA-INHOUSE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 35 GLOBAL CRO IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 36 GLOBAL ACADEMIA IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 37 GLOBAL OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 38 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 39 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 40 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 41 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 42 NORTH AMERICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 43 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 44 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)

TABLE 45 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 46 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 47 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 48 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 49 U.S. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 50 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 51 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)

TABLE 52 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 53 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 54 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 55 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 56 CANADA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 57 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 58 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)

TABLE 59 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 60 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 61 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 62 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 63 MEXICO DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 64 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 65 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)

TABLE 66 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 67 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 68 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 69 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 70 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 71 EUROPE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 72 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 73 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)

TABLE 74 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 75 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 76 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 77 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 78 GERMANY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 79 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 80 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 81 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 82 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 83 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 84 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 85 FRANCE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 86 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 87 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 88 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 89 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 90 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 91 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 92 U.K. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 93 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 94 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 95 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 96 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 97 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 98 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 99 ITALY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 100 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 101 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 102 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 103 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 104 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 105 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 106 SPAIN DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 107 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 108 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 109 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 110 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 111 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 112 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 113 RUSSIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 114 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 115 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 116 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 117 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 118 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 119 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 120 TURKEY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 121 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 122 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 123 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 124 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 125 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 126 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 127 BELGIUM DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 128 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 129 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 130 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 131 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 132 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 133 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 134 NETHERLANDS DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 135 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 136 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 137 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 138 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 139 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 140 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 141 SWITZERLAND DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 142 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 143 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 144 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 145 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 146 REST OF EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 147 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 148 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 149 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 150 ASIA-PACIFIC DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 151 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 152 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)

TABLE 153 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 154 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 155 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 156 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 157 JAPAN DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 158 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 159 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 160 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 161 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 162 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 163 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 164 CHINA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 165 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 166 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 167 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 168 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 169 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 170 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 171 SOUTH KOREA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 172 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 173 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 174 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 175 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 176 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 177 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 178 INDIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 179 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 180 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 181 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 182 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 183 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 184 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 185 AUSTRALIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 186 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 187 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 188 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 189 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 190 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 191 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 192 SINGAPORE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 193 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 194 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 195 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 196 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 197 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 198 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 199 THAILAND DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 200 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 201 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 202 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 203 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 204 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 205 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 206 MALAYSIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 207 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 208 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 209 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 210 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 211 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 212 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 213 INDONESIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 214 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 215 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 216 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 217 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 218 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 219 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 220 PHILIPPINES DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 221 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 222 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 223 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 224 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 225 REST OF ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 226 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 227 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 228 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 229 SOUTH AMERICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 230 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 231 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)

TABLE 232 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 233 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 234 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 235 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 236 BRAZIL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 237 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 238 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 239 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 240 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 241 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 242 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 243 ARGENTINA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 244 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 245 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 246 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 247 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 248 REST OF SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 249 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 250 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 251 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 252 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 253 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 254 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 255 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 256 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 257 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 258 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 259 SOUTH AFRICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 260 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 261 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 262 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 263 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 264 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 265 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 266 SAUDI ARABIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 267 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 268 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 269 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 270 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 271 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 272 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 273 U.A.E. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 274 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 275 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 276 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 277 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 278 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 279 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 280 EGYPT DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 281 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 282 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 283 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 284 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 285 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

TABLE 286 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 287 ISRAEL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 288 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)

TABLE 289 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)

TABLE 290 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)

TABLE 291 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 292 REST OF MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)

图片列表

FIGURE 1 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION

FIGURE 2 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: MARKET END USERS COVERAGE GRID

FIGURE 8 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION

FIGURE 11 RISING PREVALENCE OF NEUROLOGICAL DISORDER IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET FROM 2023 TO 2030

FIGURE 12 IMAGING MODALITY TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET IN 2023 & 2030

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET SERVICE PROVIDERS IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET

FIGURE 16 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY IMAGING MODALITY TYPE, 2022

FIGURE 17 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY APPLICATION, 2022

FIGURE 18 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY THERAPEUTIC AREA, 2022

FIGURE 19 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY BIOLOGICAL VARIABLE, 2022

FIGURE 20 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY TEMPORAL FORMAT OF USE, 2022

FIGURE 21 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY END USER, 2022

FIGURE 22 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SNAPSHOT (2022)

FIGURE 23 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%)

FIGURE 24 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%)

FIGURE 25 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%)

FIGURE 26 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%)

查看详细信息

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

How big is the in vivo preclinical brain imaging devices market?

The in vivo preclinical brain imaging devices market size will be worth USD 1,124,983.68 thousand by 2030.

What is the growth rate of the in vivo preclinical brain imaging devices market?

The growth rate of the in vivo preclinical brain imaging devices market is 5.9% by 2030.

What are the growth drivers of the in vivo preclinical brain imaging devices market?

Rising prevalence of neurological disorders & advancements in imaging techniques used in brain imaging are the growth drivers of the in vivo preclinical brain imaging devices market.

What are the factors on which the in vivo preclinical brain imaging devices market research is based on?

Imaging modality type, application, therapeutic area, biological variable, temporal format of use, and end user are the factors on which the in vivo preclinical brain imaging devices market research is based.

Which are the major companies in the in vivo preclinical brain imaging devices market?

Major companies in the in vivo preclinical brain imaging devices market are PerkinElmer Inc., FUJIFILM Corporation, Mediso Ltd., Spectral Instruments Imaging, MR Solutions, Charles River Laboratories, Aspect Imaging Ltd., Bruker, Miltenyi Biotec, MILabs B.V., and Cubresa Inc.

Forecast Period	2024 –2030
Market Size (Base Year)	USD MILLION Request
Market Size (Forecast Year)	USD 1,124,983.68
CAGR	5.90 %
Major Markets Players	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 Request For Unlock

全球体内临床前脑成像设备市场 – 行业趋势和 2030 年预测

全球体内临床前脑成像设备市场 – 行业趋势和 2030 年预测

Global In Vivo Preclinical Brain Imaging Devices Market

CAGR : 5.90 %

体内临床前脑成像设备市场分析和规模

全球体内临床前脑成像设备市场动态

全球体内临床前脑成像设备市场范围

全球体内临床前脑成像设备市场区域分析/见解

竞争格局和全球体内临床前脑成像设备市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

报告

市场洞察

支持

解决方案

全球体内临床前脑成像设备市场 – 行业趋势和 2030 年预测

全球体内临床前脑成像设备市场 – 行业趋势和 2030 年预测

Global In Vivo Preclinical Brain Imaging Devices Market

CAGR : 5.90 %

体内临床前脑成像设备市场分析和规模

全球体内临床前脑成像设备市场动态

全球体内临床前脑成像设备市场范围

全球体内临床前脑成像设备市场区域分析/见解

竞争格局和全球体内临床前脑成像设备市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

浏览相关页面